Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Virgin Wines UK (VINO) by Steve Moore in ShareProphets
- Hold SEGRO (SGRO) by Jefferies
- Avoid Pennant International Group (PEN) by Steve Moore in ShareProphets
- Buy CMC Markets (CMCX) by Paul Summers in The Motley Fool
- Buy AstraZeneca (AZN) by LBBW
- Watch Empresaria Group (EMR) by Steve Moore in ShareProphets
- Buy Centamin (DI) (CEY) by Nigel Somerville in ShareProphets
- Neutral Ryanair Holdings (CDI) (0RYA) by UBS
- Buy Relx plc (REL) by UBS
- Sell Unilever (ULVR) by UBS
- Hold AstraZeneca (AZN) by DZ Bank
- Buy British American Tobacco (BATS) by Deutsche Bank
- Hold Hammerson (HMSO) by Deutsche Bank
- Buy Computacenter (CCC) by Jefferies
- Buy Man Group (EMG) by Goldman Sachs
- Sell Deliveroo Class (ROO) by Redburn
- Buy Unilever (ULVR) by Deutsche Bank
- Buy 3i Group (III) by Lauren Almeida in The Times - Tempus
- Overweight BT Group (BT.A) by Barclays
- Overweight IG Group Holdings (IGG) by Barclays
Allergy Therapeutics (AGY) Share Price
Health Care Sector
NOTE: This is based on 22 open tips for Allergy Therapeutics (AGY)
| Latest Bid : 4.60p | Latest Ask : 4.80p |
| High Today : 5.20p | Low Today : 4.60p |
| This Years High : 6.00p | This Years Low : 1.30p |
| Volume : 574,364 | MKT Cap : £228.77M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Allergy Therapeutics (AGY) Overview
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.Allergy Therapeutics (AGY) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2024-02-14 13:40:00 14/02/2024 | -108.70% |
| Avoid | Steve Moore | Premium Only | 2023-08-10 11:35:00 10/08/2023 | -100.00% |
| Avoid | Steve Moore | Premium Only | 2022-12-29 10:45:00 29/12/2022 | -20.00% |
| Avoid | Steve Moore | Premium Only | 2022-07-15 16:05:00 15/07/2022 | 70.00% |
| Corporate | FinnCap | Premium Only | 2020-03-04 10:50:00 04/03/2020 | – |
Allergy Therapeutics (AGY) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 4.60p | Latest Ask : 4.80p |
| High Today : 5.20p | Low Today : 4.60p |
| This Years High : 6.00p | This Years Low : 1.30p |
| Volume : 574,364 | MKT Cap : £228.77M |
Allergy Therapeutics Overview
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Allergy Therapeutics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2024-02-14 13:40:00 14/02/2024 | -108.70% |
| Avoid | Steve Moore | Premium Only | 2023-08-10 11:35:00 10/08/2023 | -100.00% |
| Avoid | Steve Moore | Premium Only | 2022-12-29 10:45:00 29/12/2022 | -20.00% |
| Avoid | Steve Moore | Premium Only | 2022-07-15 16:05:00 15/07/2022 | 70.00% |
| Corporate | FinnCap | Premium Only | 2020-03-04 10:50:00 04/03/2020 | – |